Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Ames

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Blood|April 15, 2021
Polytypic T-cell prolymphocytic leukemiaErik Ames, Oscar Silva
Cancer Immunology, Immunotherapy : CII|August 31, 2013
Advantages and clinical applications of natural killer cells in cancer immunotherapyErik Ames, William J Murphy
Transplantation|August 30, 2014
The authors' replyErik Ames, William J Murphy
Clinical Chemistry and Laboratory Medicine|April 11, 2022
Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturerErik Ames, Raffick A R Bowen
Blood Advances|May 8, 2026
Immunophenotyping challenges in the diagnosis of NK-LGLLAaron J Wilk, Jean S Oak, Erik Ames
Journal of Gastrointestinal Oncology|April 2, 2016
Immune targeting of cancer stem cells in gastrointestinal oncologyRobert J Canter, Steven K Grossenbacher, Erik Ames, et al.
NPJ Precision Oncology|August 9, 2025
Detection of cytogenetically cryptic PML-RARA fusion in acute promyelocytic leukemia by rapid next generation sequencingHailee St Louis, Nicholas Protopsaltis, Erik Ames, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 22, 2011
The triterpenoid CDDO-Me promotes hematopoietic progenitor expansion and myelopoiesis in miceErik Ames, Salif Harouna, Colin Meyer, et al.
Diagnostic Cytopathology|February 27, 2018
Sclerosing mucoepidermoid carcinoma with eosinophilia: Cytologic characterization of a rare distinct entity in the thyroidErik Ames, Michael J Campbell, Alaa Afify, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 12, 2013
Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistanceMaite Alvarez, Can M Sungur, Erik Ames, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Blood|April 15, 2021
Polytypic T-cell prolymphocytic leukemiaErik Ames, Oscar Silva
Cancer Immunology, Immunotherapy : CII|August 31, 2013
Advantages and clinical applications of natural killer cells in cancer immunotherapyErik Ames, William J Murphy
Transplantation|August 30, 2014
The authors' replyErik Ames, William J Murphy
Clinical Chemistry and Laboratory Medicine|April 11, 2022
Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturerErik Ames, Raffick A R Bowen
Blood Advances|May 8, 2026
Immunophenotyping challenges in the diagnosis of NK-LGLLAaron J Wilk, Jean S Oak, Erik Ames
Journal of Gastrointestinal Oncology|April 2, 2016
Immune targeting of cancer stem cells in gastrointestinal oncologyRobert J Canter, Steven K Grossenbacher, Erik Ames, et al.
NPJ Precision Oncology|August 9, 2025
Detection of cytogenetically cryptic PML-RARA fusion in acute promyelocytic leukemia by rapid next generation sequencingHailee St Louis, Nicholas Protopsaltis, Erik Ames, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 22, 2011
The triterpenoid CDDO-Me promotes hematopoietic progenitor expansion and myelopoiesis in miceErik Ames, Salif Harouna, Colin Meyer, et al.
Diagnostic Cytopathology|February 27, 2018
Sclerosing mucoepidermoid carcinoma with eosinophilia: Cytologic characterization of a rare distinct entity in the thyroidErik Ames, Michael J Campbell, Alaa Afify, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 12, 2013
Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistanceMaite Alvarez, Can M Sungur, Erik Ames, et al.
Pageof 3